DarioHealth
About
DarioHealth Corp. (Nasdaq: DRIO) is a US-based global digital health and digital therapeutics company that helps people manage chronic conditions such as diabetes, hypertension, weight and behavioral health through a user-centric, multi-condition platform. In early 2024 it acquired fellow digital health firm Twill for approximately $224 million, roughly doubling pro forma revenue. It reported full-year 2024 revenue of about $27 million and sells largely through employer and health-plan channel partnerships.
Latest news
Checking the news desk for fresh coverage…
Coverage gathered from public sources.
Why Healthtech
Founders using technology to widen access, lower cost and shift care from reactive to anticipatory - across diagnostics, chronic care, and life-sciences tooling.